Evaxion A/S - EVAX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$6.807M
QoQ value delta ($000)
+$1.806M (+36.11%)
Implied price effect (QoQ)
+26.8%
Shares
Total shares
1,428,379
QoQ shares delta
+97,696 (+7.34%)
Total shares held by funds (by quarter)

Market chart (EVAX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Merck & Co., Inc. 5,791 1,214,126 2.1%
Ikarian Capital, LLC 356 74,698 0.03%
Point72 Asset Management, L.P. 157 33,100 0.0%
RHUMBLINE ADVISERS 100 21,090 0.0%
Stonepine Capital Management, LLC 95 20,000 0.07%
BOOTHBAY FUND MANAGEMENT, LLC 87 18,426 0.0%
SmartHarvest Portfolios, LLC 72 15,194 0.03%
WESBANCO BANK INC 47 10,000 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 38 8,000 0.0%
ROYAL BANK OF CANADA 19 3,900 0.0%
GAMMA Investing LLC 18 3,841 0.0%
UBS Group AG 15 3,217 0.0%
EverSource Wealth Advisors, LLC 12 2,707 0.0%
BESSEMER GROUP INC 0 18 0.0%
SBI Securities Co., Ltd. 0 62 0.0%